webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

DBCO-PEG2-NHS ester

  CAS No.: 2585653-12-7   Cat No.: BADC-01658 4.5  

DBCO-PEG2-NHS ester is a bioorthogonal ADC linker combining DBCO reactive group with PEG2 spacer and NHS ester. It enables efficient site-specific payload conjugation via SPAAC click chemistry, enhancing antibody-drug conjugate stability and efficacy.

DBCO-PEG2-NHS ester

Structure of 2585653-12-7

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C30H31N3O8
Molecular Weight
561.59
Shipping
Ambient temperature
Shipping
-20 °C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[[4-(2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-4-oxobutanoyl]amino]ethoxy]ethoxy]propanoate
Canonical SMILES
C1CC(=O)N(C1=O)OC(=O)CCOCCOCCNC(=O)CCC(=O)N2CC3=CC=CC=C3C#CC4=CC=CC=C42
InChI
InChI=1S/C30H31N3O8/c34-26(31-16-18-40-20-19-39-17-15-30(38)41-33-28(36)13-14-29(33)37)11-12-27(35)32-21-24-7-2-1-5-22(24)9-10-23-6-3-4-8-25(23)32/h1-8H,11-21H2,(H,31,34)
InChIKey
WEMCNVHTFXFLHG-UHFFFAOYSA-N
Appearance
Yellow to brown Oil
Shipping
Ambient temperature
Storage
-20 °C

DBCO-PEG2-NHS ester is a bifunctional reagent widely used for bioconjugation applications. Here are some key applications of DBCO-PEG2-NHS ester:

Protein Labeling: DBCO-PEG2-NHS ester facilitates the covalent attachment of proteins to a variety of surfaces or other biomolecules via click chemistry. By reacting with amine groups on proteins, researchers can achieve site-specific labeling without compromising protein function. This technique is essential for studying protein localization, interactions, and dynamics in complex biological systems.

Drug Delivery Systems: DBCO-PEG2-NHS ester is instrumental in the development of targeted drug delivery systems. By conjugating therapeutic agents to targeting ligands through PEG linkers, it ensures efficient and specific delivery to diseased tissues. This approach improves the therapeutic index of drugs and reduces off-target effects.

Biosensor Development: In biosensor technology, DBCO-PEG2-NHS ester is used to immobilize biomolecules on sensor surfaces. This enables the creation of highly sensitive and specific detection platforms for various analytes, including proteins, nucleic acids, and small molecules. Such biosensors are valuable in diagnostics, environmental monitoring, and food safety.

Surface Modification: DBCO-PEG2-NHS ester is utilized to modify the surfaces of nanoparticles, beads, and other materials to enhance their biocompatibility and functionality. By attaching bioligands or antifouling agents, these modified surfaces exhibit improved performance in biomedical applications such as imaging, biosensing, and therapeutics. This helps ensure that the materials interact with biological systems in a predictable and favorable manner.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Mal-Phe-C4-Val-Cit-PAB | Methotrexate-d3 | tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11,14,17,20,23,26,29,32,35-undecaoxa-2-azaheptatriacontan-37-ylcarbamate | Biotin-sar-oh | DBCO-Peg4-VC-PAB-MMAE | 4-nitrophenyl 2-(pyridin-2-yldisulfanyl)propyl carbonate | DBCO-PEG4-DBCO | DBCO-PEG2-NHS ester
Send Inquiry
Verification code
Inquiry Basket